Pharmaceutical & Biotechnology Environment Monitoring Market Players:
- Thermo Fisher Scientific Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Springer Nature Limited
- Applied Microarrays Inc.
- C D Genomics
- RELX Group
- MilliporeSigma
- QIAGEN
- Agilent Technologies, Inc.
- Danaher Corporation
- Eppendorf SE
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of pharmaceutical & biotechnology environment monitoring is assessed at USD 1.3 billion.
The global pharmaceutical & biotechnology environment monitoring market size was valued at more than USD 1.23 billion in 2025 and is expected to register a CAGR of over 6.6%, exceeding USD 2.33 billion revenue by 2035.
The Asia Pacific region is anticipated to capture a 35% share by 2035 in the pharmaceutical & biotechnology environment monitoring market, spurred by the rapid adoption of advanced biotechnology and rising investment in regional biotech enterprises.
Key players in the market include Thermo Fisher Scientific Company, Springer Nature Limited, Applied Microarrays Inc., C D Genomics, RELX Group, MilliporeSigma, QIAGEN, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE.
